Government Agencies FDA

  • Dr. Scott Gottlieb, commissioner of the Food and Drug Administration

    Gottlieb rolled out new rules Thursday restricting retail sales of most flavored e-cigarettes mostly to vape shops and other stores that don't allow minors. Most convenience stores and gas stations will effectively be banned.

  • Nov 15- The U.S. Food and Drug Administration on Thursday announced sweeping new restrictions on flavored tobacco products, including electronic cigarettes popular among teenagers in an effort to prevent a new generation of nicotine addicts. The FDA also plans to seek a ban on menthol cigarettes, a longtime goal of public health advocates, as well as flavored...

  • A model smokes a Juul e-cig during New York Fashion Week.

    Food and Drug Administration Commissioner Scott Gottlieb outlined a slew of policies, including restrictions on sales of flavored e-cigarettes, and essentially threatened to pull products from the market if manufacturers do not follow them. 

  • Juul pulls some nicotine flavors from retail stores

    The "Squawk Box" news team discusses some of the morning's most provocative headlines.

  • Fontem Ventures, a unit of tobacco company Imperial Brands, says it will raise the minimum age requirements to buy nicotine pods on its website to 21 regardless of where consumers are shopping.

  • Brenda Wisehart smokes a menthol cigarette in front of a Quick Stop store.  

    FDA Commissioner Dr. Scott Gottlieb plans to announce this week the agency will move forward with a ban on menthol cigarettes, senior FDA officials told CNBC last week. 

  • LONDON, Nov 12- European shares bounced back on Monday thanks to strong oil stocks, while tobacco firms were dented by new signs of regulators tightening the screws on menthol cigarettes. British American Tobacco shares fell as much as 11 percent to its lowest since February 2014 after a Wall Street Journal report that the U.S. Food and Drug Administration plans...

  • Juul Labs' e-cigarette flavored pods. Each pod delivers around 200 puffs, with a 5 percent nicotine weight, and is available to purchase in packs of four.  

    E-cigarette manufacturer Juul will stop selling fruity flavors like mango and cucumber from brick and mortar stores in response to the Food and Drug Administration's request to curb "epidemic" levels of teen vaping.

  • Dr. Scott Gottlieb, commissioner of the Food and Drug Administration

    Laura Perryman expected her medical company, Stimwave Technologies, would have to wait several years for its painkilling device to win U.S. approval as a treatment for chronic migraines.  

  • A person smokes a Juul Labs Inc. e-cigarette in this arranged photograph taken in the Brooklyn Borough of New York, U.S., on Sunday July 8, 2018. 

    The FDA plans to limit sales of some flavored e-cigarettes to vape shops and to ban menthol cigarettes, senior agency officials tell CNBC. 

  • Nov 8- The U.S. Food and Drug Administration is expected to announce a ban on the sale of flavored e-cigarettes in convenience stores and gas stations across the country as soon as next week, the Washington Post reported on Thursday. The FDA will also impose rules such as age-verification requirements for online sales, the paper reported...

  • The list price of $4,175 per unit set by Coherus is the same as Mylan NV's biosimilar Fulphila that was approved earlier this year. Udenyca, the second approved copycat version to Neulasta, received approval from the U.S. Food and Drug Administration last week. Neulasta, used to fight infections in cancer patients, has a list price of $6,231 per unit, and brought...

  • Tobacco smoking cigarette

    An estimated 14 percent of adults in the U.S., or 34.3 million people, smoked cigarettes in 2017, according to the Centers for Disease Control and Prevention.

  • Conagra on Monday had recalled four varieties of the cake mix after officials in Oregon found Salmonella agbeni in a box of Duncan Hines Classic White Cake Mix. The U.S. Food and Drug Administration and the Centers for Disease Control and Prevention are investigating five illnesses in three states to determine if they are linked with recently recalled...

  • U.S. generic drugmakers such as Mylan and Teva Pharmaceutical Industries Ltd have suffered over the past few years as a steep fall in generic prices weighed on their bottom lines. The company said on Monday the U.S. Food and Drug Administration was in the final stage of reviewing the label of its generic version of GlaxoSmithKline Plc's blockbuster asthma...

  • Nov 2- Pfizer Inc said on Friday the U.S. Food and Drug Administration has approved its lung-cancer treatment for patients with a specific gene mutation who had been previously treated for an aggressive form of the disease. The treatment, Lorbrena, is designed to treat advanced non-small cell lung cancer in patients with a mutation of the ALK gene, who have...

  • Nov 2- An advisory panel to the U.S. Food and Drug Administration on Friday recommended Sage Therapeutics Inc's experimental treatment for postpartum depression, saying the benefits of the drug outweighed risks. The decision comes https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drug s/ P s y c h o p h a r m a c o l o g i c D r u g s A d...

  • Nov 2- The U.S. Food and Drug Administration on Friday approved AcelRx Pharmaceuticals Inc's opioid-based fast-acting treatment for pain to be used under medical supervision. An FDA panel in October voted 10-3 in favor of Dsuvia's approval after the company reworked its application by halving the maximum dosage to 12 pills a day, and making certain changes to...

  • Juul's e-cigarettes have gotten a bad rap as federal officials question whether their popular candy flavors are responsible for a spike in teen use. Anecdotal evidence suggests some adults use the nicotine pods as they were intended: to quit smoking.

  • The decision comes two days after FDA staff reviewers https://bit.ly/2QegxPF flagged abuse potential for the opioid-based depression treatment and raised questions on its efficacy. FDA staffers in the review on Tuesday also questioned the non-availability of trial data on the effects of the treatment on unborn infants when the treatment was...